Association analysis of common variants of ELN, NOS2A, APOE and ACE2 to intracranial aneurysm

Department of Health and Environmental Sciences, Kyoto University, Kioto, Kyōto, Japan
Stroke (Impact Factor: 6.02). 06/2006; 37(5):1189-94. DOI: 10.1161/01.STR.0000217408.91389.4d
Source: PubMed

ABSTRACT Previous studies have shown positive evidence of linkage of the intracranial aneurysm (IA) at chromosome 7q11, 17cen, 19q13, and Xp22. These regions contain elastin (ELN), nitric oxide synthetase 2A (NOS2A), apolipoprotein E (APOE), and angiotensin-I converting enzyme 2 (ACE2), which are considered to be promising candidate genes for IA. We aimed to examine the association of single-nucleotide polymorphisms (SNPs) with IA in these candidate genes.
To identify polymorphisms in NOS2A and ACE2, all exons and exon-intron boundaries were screened by direct sequencing in 30 randomly selected controls. The program tagSNPs was used to select an optimal set of haplotype-tagging SNPs. For ELN and APOE, SNPs were selected from previous reports. These selected SNPs were then genotyped in 362 cases with IA and 332 residential area matched controls. THESIAS software was used to investigate the association of alleles and haplotypes with IA by adjusting with covariates.
We genotyped 8 SNPs in ELN, 8 SNPs in NOS2A, 3 epsilon alleles in APOE and 1 SNP in ACE2. No alleles or haplotypes of 4 candidate genes revealed any significant association with IA.
Investigated polymorphisms in this study were not associated with IA.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Cerebral saccular aneurysm is a major cause of subarachnoid hemorrhage, one of the cerebrovascular diseases with the highest mortality. The mechanisms underlying the development of aneurysm, however, still remain unclear. Objective: The authors have made a series of reports on an animal model of experimentally induced cerebral aneurysms that resemble human cerebral aneurysms in their location and morphology. The objective of this brief review is to introduce our evidence about the pathogenesis of cerebral aneurysms using the experimentally induced cerebral aneurysm model, particularly focused upon the role of nitric oxide (NO) and shear stress on degenerative changes of the arterial wall during aneurysm development. Methods: We first introduce methods of aneurysm-inducing surgery, and then refer to morphological analysis of aneurysmal induction. Next, we explain the association between aneurysmal development and shear stress and NO. Finally, we show several mechanisms of aneurysmal development using genetically modified animals. Results and conclusion: In our animal model, cerebral aneurysms are induced in rats, monkeys, and mice by ligation of the unilateral common carotid artery and renal hypertension, suggesting that an increase in hemodynamic stress is a key requirement for the aneurysm development. Our morphological and molecular studies suggest that increased wall shear stress, iNOS-derived NO, MMP-2 & 9, cathepsin B, NF-κB, interleukin-1β, and endothelin B receptor are associated with the progression of cerebral aneurysms. Statin and Nifedipine may be possible drugs for the prevention of cerebral aneurysm development.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Biological markers that can be used to predict the risk of intracranial aneurysms (IAs) are not available.
    Journal of the American Heart Association 09/2014; 3(5). DOI:10.1161/JAHA.114.000972 · 2.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Subarachnoid hemorrhage secondary to rupture of an intracranial aneurysm is a highly lethal medical condition. Current management strategies for unruptured intracranial aneurysms involve radiological surveillance and neurosurgical or endovascular interventions. There is no pharmacological treatment available to decrease the risk of aneurysm rupture and subsequent subarachnoid haemorrhage. There is growing interest in the pathogenesis of intracranial aneurysm focused on the development of drug therapies to decrease the incidence of aneurysm rupture. The study of rodent models of intracranial aneurysms has the potential to improve our understanding of intracranial aneurysm development and progression. This review summarises current mouse models of intact and ruptured intracranial aneurysms and discusses the relevance of these models to human intracranial aneurysms. The article also reviews the importance of these models in investigating the molecular mechanisms involved in the disease. Finally, potential pharmaceutical targets for intracranial aneurysm suggested by previous studies are discussed. Examples of potential drug targets include matrix metalloproteinases, stromal cell-derived factor-1, tumor necrosis factor-α, the renin-angiotensin system and the β estrogen receptor. An agreed clear, precise and reproducible definition of what constitutes an aneurysm in the models would assist in their use to better understand the pathology of intracranial aneurysm and apply findings to patients.
    Brain Pathology 07/2014; 25(3). DOI:10.1111/bpa.12175 · 4.35 Impact Factor

Similar Publications